{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:46Z","timestamp":1787020786216,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Youth of National Natural Science Foundation of China","award":["81803091"],"award-info":[{"award-number":["81803091"]}]},{"name":"Resident Standardization Training Foundation of Zhongshan Hospital","award":["2020-ZP-085"],"award-info":[{"award-number":["2020-ZP-085"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer-associated cachexia is a multifactorial syndrome defined by progressive weight loss with ongoing loss of adipose tissue and skeletal muscle. Adipose loss occurs in the early stage of cachexia and is associated with reduced quality of life and survival time. Although numerous lncRNAs are regarded as novel regulators in adipose metabolism, the role of lncRNAs that selectively modulate the development of adipose loss in cachexia remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we analyzed microarray data of lncRNAs in adipose loss and further explored the function and mechanism of MALAT1 in adipose loss. First, we explored the expression and function of MALAT1 in adipose cell by quantitative PCR and RNA knockdown. Subsequently, the mechanism of MALAT1 involvement in adipose loss was analyzed via RNA-seq, bioinformatics analysis and reporter gene assay. Finally, we explored the clinical significance of MALAT1 through correlation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cellular experiments revealed that knocking down MALAT1 significantly inhibited the process of adipogenesis. RNA-seq data showed that numerous adipogenic genes were downregulated upon MALAT1 knockdown. A protein\u2013protein interaction network analysis identified PPAR-\u03b3 as the central node transcription factor, the inhibition of which explains the downregulation of numerous adipogenic genes. A reporter gene assay suggested that MALAT1 can regulate the gene expression of PPAR-\u03b3 at the transcriptional level. Moreover, MALAT1 was weakly expressed in the subcutaneous white adipose tissue of cancer-associated cachexia patients and was related to low fat mass index and poor prognosis in cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study indicated that MALAT1 is associated with adipose loss in cancer-associated cachexia by regulating adipogenesis through PPAR-\u03b3, which may potentially be a novel target for the diagnosis and treatment of cancer-associated cachexia in the clinic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12986-021-00557-0","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T06:04:04Z","timestamp":1615356244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The long noncoding RNA MALAT1 modulates adipose loss in cancer-associated cachexia by suppressing adipogenesis through PPAR-\u03b3"],"prefix":"10.1186","volume":"18","author":[{"given":"Jun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangjun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9490-4200","authenticated-orcid":false,"given":"Guohao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"557_CR1","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"557_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"557_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10(2):90\u20139.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"557_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1743-7075-9-76","volume":"9","author":"M Olivan","year":"2012","unstructured":"Olivan M, Springer J, Busquets S, Tschirner A, Figueras M, Toledo M, Fontes-Oliveira C, Genovese MI, Ventura da Silva P, Sette A, et al. Theophylline is able to partially revert cachexia in tumour-bearing rats. Nutr Metab (Lond). 2012;9(1):76.","journal-title":"Nutr Metab (Lond)"},{"key":"557_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40170-018-0176-5","volume":"6","author":"P Malvi","year":"2018","unstructured":"Malvi P, Chaube B, Singh SV, Mohammad N, Vijayakumar MV, Singh S, Chouhan S, Bhat MK. Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state. Cancer Metab. 2018;6:2.","journal-title":"Cancer Metab"},{"key":"557_CR6","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1158\/1538-7445.AM2018-5463","volume":"78","author":"N Muhammad","year":"2018","unstructured":"Muhammad N, Rashmi R, Ruiz F, Zahner MC, Schwarz JK. Abstract 5463: Free fatty acids augment radiation-induced cytotoxicity in cervical cancer cells via mTOR\/Akt\/\/PPARg\/p53-mediated pathway. Can Res. 2018;78:5463\u20135463.","journal-title":"Can Res"},{"issue":"11","key":"557_CR7","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.3390\/nu6115280","volume":"6","author":"M Ebadi","year":"2014","unstructured":"Ebadi M, Mazurak VC. Evidence and mechanisms of fat depletion in cancer. Nutrients. 2014;6(11):5280\u201397.","journal-title":"Nutrients"},{"issue":"8","key":"557_CR8","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","volume":"25","author":"D Blum","year":"2014","unstructured":"Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, Fearon K, Strasser F, Kaasa S, Euro I. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model\u2014a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014;25(8):1635\u201342.","journal-title":"Ann Oncol"},{"key":"557_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.09.001","volume":"54","author":"SM Kazemi-Bajestani","year":"2016","unstructured":"Kazemi-Bajestani SM, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol. 2016;54:2\u201310.","journal-title":"Semin Cell Dev Biol"},{"key":"557_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.semcdb.2015.10.039","volume":"54","author":"M Tsoli","year":"2016","unstructured":"Tsoli M, Swarbrick MM, Robertson GR. Lipolytic and thermogenic depletion of adipose tissue in cancer cachexia. Semin Cell Dev Biol. 2016;54:68\u201381.","journal-title":"Semin Cell Dev Biol"},{"issue":"8","key":"557_CR11","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6603360","volume":"95","author":"C Bing","year":"2006","unstructured":"Bing C, Russell S, Becket E, Pope M, Tisdale MJ, Trayhurn P, Jenkins JR. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer. 2006;95(8):1028\u201337.","journal-title":"Br J Cancer"},{"issue":"2","key":"557_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381\u2013410.","journal-title":"Physiol Rev"},{"issue":"6","key":"557_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cancers12061605","volume":"12","author":"JK Kays","year":"2020","unstructured":"Kays JK, Koniaris LG, Cooper CA, Pili R, Jiang G, Liu Y, Zimmers TA. The combination of low skeletal muscle mass and high tumor interleukin-6 associates with decreased survival in clear cell renal cell carcinoma. Cancers (Basel). 2020;12(6):1605.","journal-title":"Cancers (Basel)"},{"key":"557_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12986-019-0409-9","volume":"16","author":"J Han","year":"2019","unstructured":"Han J, Lu C, Meng Q, Halim A, Yean TJ, Wu G. Plasma concentration of interleukin-6 was upregulated in cancer cachexia patients and was positively correlated with plasma free fatty acid in female patients. Nutr Metab (Lond). 2019;16:80.","journal-title":"Nutr Metab (Lond)"},{"issue":"36","key":"557_CR15","doi-asserted-by":"publisher","first-page":"58595","DOI":"10.18632\/oncotarget.11193","volume":"7","author":"N Muhammad","year":"2016","unstructured":"Muhammad N, Bhattacharya S, Steele R, Ray RB. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget. 2016;7(36):58595\u2013605.","journal-title":"Oncotarget"},{"issue":"2","key":"557_CR16","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/jcb.26328","volume":"119","author":"H Liu","year":"2018","unstructured":"Liu H, Zhou T, Wang B, Li L, Ye D, Yu S. Identification and functional analysis of a potential key lncRNA involved in fat loss of cancer cachexia. J Cell Biochem. 2018;119(2):1679\u201388.","journal-title":"J Cell Biochem"},{"issue":"7","key":"557_CR17","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/ijc.32236","volume":"145","author":"L Shen","year":"2019","unstructured":"Shen L, Han J, Wang H, Meng Q, Chen L, Liu Y, Feng Y, Wu G. Cachexia-related long noncoding RNA, CAAlnc1, suppresses adipogenesis by blocking the binding of HuR to adipogenic transcription factor mRNAs. Int J Cancer. 2019;145(7):1809\u201321.","journal-title":"Int J Cancer"},{"issue":"4","key":"557_CR18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/cancers12041004","volume":"12","author":"JMO Santos","year":"2020","unstructured":"Santos JMO, Peixoto-da-Silva S, Gil-da-Costa RM, Medeiros R. The emerging role of MicroRNAs and other non-coding RNAs in cancer Cachexia. Cancers (Basel). 2020;12(4):1004.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"557_CR19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50(12):1705\u201315.","journal-title":"Nat Genet"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/celldisc.2017.2","volume":"3","author":"X Chen","year":"2017","unstructured":"Chen X, He L, Zhao Y, Li Y, Zhang S, Sun K, So K, Chen F, Zhou L, Lu L, et al. Malat1 regulates myogenic differentiation and muscle regeneration through modulating MyoD transcriptional activity. Cell Discov. 2017;3:17002.","journal-title":"Cell Discov"},{"issue":"1","key":"557_CR21","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41467-018-03394-7","volume":"9","author":"CL Lino Cardenas","year":"2018","unstructured":"Lino Cardenas CL, Kessinger CW, Cheng Y, MacDonald C, MacGillivray T, Ghoshhajra B, Huleihel L, Nuri S, Yeri AS, Jaffer FA, et al. An HDAC9-MALAT1-BRG1 complex mediates smooth muscle dysfunction in thoracic aortic aneurysm. Nat Commun. 2018;9(1):1009.","journal-title":"Nat Commun"},{"key":"557_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2018.08.009","volume":"436","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wu C, Zhang C, Li Z, Zhu T, Chen J, Ren Y, Wang X, Zhang L, Zhou X. TGF-beta-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1\/miR-30a interactions. Cancer Lett. 2018;436:52\u201362.","journal-title":"Cancer Lett"},{"issue":"9","key":"557_CR23","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1158\/0008-5472.CAN-15-2018","volume":"76","author":"E Latorre","year":"2016","unstructured":"Latorre E, Carelli S, Raimondi I, D\u2019Agostino V, Castiglioni I, Zucal C, Moro G, Luciani A, Ghilardi G, Monti E, et al. The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial\u2013mesenchymal transition in breast cancer. Cancer Res. 2016;76(9):2626\u201336.","journal-title":"Cancer Res"},{"issue":"5","key":"557_CR24","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/ijms21051628","volume":"21","author":"K Hitachi","year":"2020","unstructured":"Hitachi K, Nakatani M, Funasaki S, Hijikata I, Maekawa M, Honda M, Tsuchida K. Expression levels of long non-coding RNAs change in models of altered muscle activity and muscle mass. Int J Mol Sci. 2020;21(5):1628.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"557_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.molcel.2014.06.004","volume":"55","author":"XY Zhao","year":"2014","unstructured":"Zhao XY, Li S, Wang GX, Yu Q, Lin JD. A long noncoding RNA transcriptional regulatory circuit drives thermogenic adipocyte differentiation. Mol Cell. 2014;55(3):372\u201382.","journal-title":"Mol Cell"},{"issue":"5","key":"557_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cmet.2015.04.003","volume":"21","author":"JR Alvarez-Dominguez","year":"2015","unstructured":"Alvarez-Dominguez JR, Bai Z, Xu D, Yuan B, Lo KA, Yoon MJ, Lim YC, Knoll M, Slavov N, Chen S, et al. De novo reconstruction of adipose tissue transcriptomes reveals long non-coding RNA regulators of brown adipocyte development. Cell Metab. 2015;21(5):764\u201376.","journal-title":"Cell Metab"},{"issue":"7","key":"557_CR27","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbagrm.2016.05.003","volume":"1859","author":"M Li","year":"2016","unstructured":"Li M, Sun X, Cai H, Sun Y, Plath M, Li C, Lan X, Lei C, Lin F, Bai Y, et al. Long non-coding RNA ADNCR suppresses adipogenic differentiation by targeting miR-204. Biochim Biophys Acta. 2016;1859(7):871\u201382.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"557_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"issue":"2","key":"557_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers11020216","volume":"11","author":"Y Sun","year":"2019","unstructured":"Sun Y, Ma L. New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers Basel. 2019;11(2):216.","journal-title":"Cancers Basel"},{"issue":"5","key":"557_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/0008-5472.CAN-16-1508","volume":"77","author":"P Malakar","year":"2017","unstructured":"Malakar P, Shilo A, Mogilevsky A, Stein I, Pikarsky E, Nevo Y, Benyamini H, Elgavish S, Zong X, Prasanth KV, et al. Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation. Cancer Res. 2017;77(5):1155\u201367.","journal-title":"Cancer Res"},{"issue":"8","key":"557_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.4161\/rna.21089","volume":"9","author":"M Eissmann","year":"2012","unstructured":"Eissmann M, Gutschner T, Hammerle M, Gunther S, Caudron-Herger M, Gross M, Schirmacher P, Rippe K, Braun T, Zornig M, et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 2012;9(8):1076\u201387.","journal-title":"RNA Biol"},{"issue":"1","key":"557_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2014.08.018","volume":"159","author":"JM Engreitz","year":"2014","unstructured":"Engreitz JM, Sirokman K, McDonel P, Shishkin AA, Surka C, Russell P, Grossman SR, Chow AY, Guttman M, Lander ES. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell. 2014;159(1):188\u201399.","journal-title":"Cell"},{"issue":"6","key":"557_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.molcel.2010.08.011","volume":"39","author":"V Tripathi","year":"2010","unstructured":"Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39(6):925\u201338.","journal-title":"Mol Cell"},{"issue":"8","key":"557_CR34","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/emboj.2011.65","volume":"30","author":"R Siersbaek","year":"2011","unstructured":"Siersbaek R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S. Extensive chromatin remodelling and establishment of transcription factor \u2018hotspots\u2019 during early adipogenesis. EMBO J. 2011;30(8):1459\u201372.","journal-title":"EMBO J"},{"issue":"1","key":"557_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4149\/neo_2009_01_56","volume":"56","author":"R Talar-Wojnarowska","year":"2009","unstructured":"Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E. Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma. Neoplasma. 2009;56(1):56\u201362.","journal-title":"Neoplasma"},{"issue":"1\u20132","key":"557_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cell.2014.12.005","volume":"160","author":"ME McDonald","year":"2015","unstructured":"McDonald ME, Li C, Bian H, Smith BD, Layne MD, Farmer SR. Myocardin-related transcription factor A regulates conversion of progenitors to beige adipocytes. Cell. 2015;160(1\u20132):105\u201318.","journal-title":"Cell"},{"issue":"7516","key":"557_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir S, White JP, Kleiner S, Kazak L, Cohen P, Baracos VE, Spiegelman BM. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014;513(7516):100\u20134.","journal-title":"Nature"},{"issue":"12","key":"557_CR38","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1039\/C5FO00478K","volume":"6","author":"L Du","year":"2015","unstructured":"Du L, Yang YH, Wang YM, Xue CH, Kurihara H, Takahashi K. EPA-enriched phospholipids ameliorate cancer-associated cachexia mainly via inhibiting lipolysis. Food Funct. 2015;6(12):3652\u201362.","journal-title":"Food Funct"},{"issue":"10","key":"557_CR39","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/nm.4171","volume":"22","author":"M Rohm","year":"2016","unstructured":"Rohm M, Schafer M, Laurent V, Ustunel BE, Niopek K, Algire C, Hautzinger O, Sijmonsma TP, Zota A, Medrikova D, et al. An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. Nat Med. 2016;22(10):1120\u201330.","journal-title":"Nat Med"}],"container-title":["Nutrition &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-021-00557-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12986-021-00557-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-021-00557-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T18:59:31Z","timestamp":1671562771000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-021-00557-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s12986-021-00557-0","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Zhongshan Hospital of Fudan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}